ResMed, Inc. (RMD)
236.92
-5.69
(-2.35%)
USD |
NYSE |
Nov 19, 16:00
236.73
-0.19
(-0.08%)
After-Hours: 20:00
ResMed Net Income (Quarterly) : 418.41M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 418.41M |
| June 30, 2026 | 383.43M |
| March 31, 2026 | 398.73M |
| December 31, 2025 | 392.59M |
| September 30, 2025 | 348.54M |
| June 30, 2025 | 379.70M |
| March 31, 2025 | 365.04M |
| December 31, 2024 | 344.62M |
| September 30, 2024 | 311.36M |
| June 30, 2024 | 292.24M |
| March 31, 2024 | 300.49M |
| December 31, 2023 | 208.80M |
| September 30, 2023 | 219.42M |
| June 30, 2023 | 229.66M |
| March 31, 2023 | 232.50M |
| December 31, 2022 | 224.91M |
| September 30, 2022 | 210.48M |
| June 30, 2022 | 195.06M |
| March 31, 2022 | 179.01M |
| December 31, 2021 | 201.75M |
| September 30, 2021 | 203.61M |
| June 30, 2021 | 195.10M |
| March 31, 2021 | -78.48M |
| December 31, 2020 | 179.51M |
| September 30, 2020 | 178.37M |
| Date | Value |
|---|---|
| June 30, 2020 | 177.84M |
| March 31, 2020 | 163.14M |
| December 31, 2019 | 160.55M |
| September 30, 2019 | 120.15M |
| June 30, 2019 | 68.80M |
| March 31, 2019 | 105.42M |
| December 31, 2018 | 124.64M |
| September 30, 2018 | 105.74M |
| June 30, 2018 | 109.81M |
| March 31, 2018 | 110.12M |
| December 31, 2017 | 9.527M |
| September 30, 2017 | 86.12M |
| June 30, 2017 | 101.61M |
| March 31, 2017 | 87.82M |
| December 31, 2016 | 76.74M |
| September 30, 2016 | 76.11M |
| June 30, 2016 | 83.13M |
| March 31, 2016 | 90.79M |
| December 31, 2015 | 95.58M |
| September 30, 2015 | 80.40M |
| June 30, 2015 | 87.46M |
| March 31, 2015 | 90.98M |
| December 31, 2014 | 91.18M |
| September 30, 2014 | 83.26M |
| June 30, 2014 | 87.74M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Accuray, Inc. | 10.13M |
| Orthofix Medical, Inc. | -6.074M |
| Rockwell Medical, Inc. | -2.324M |
| Microbot Medical, Inc. | -5.842M |
| Stereotaxis, Inc. | -6.482M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.415B |
| Total Expenses (Quarterly) | 996.40M |
| EPS Diluted (Quarterly) | 2.918 |
| Enterprise Value | 33.70B |
| Gross Profit Margin (Quarterly) | 61.53% |
| Profit Margin (Quarterly) | 29.57% |
| Earnings Yield | 4.63% |
| Operating Earnings Yield | 5.66% |
| Normalized Earnings Yield | 4.683 |